Slide 1: Exchange filing cover letter under Regulation 30
Ref: OAL/BSE/NSE/54/2020-21 21st October, 2020 To To The Manager The Manager Department of Corporate Services, Listing Department, BSE Limited, National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai- 400 001 Bandra (East), Mumbai -
Slide 2: Earnings Presentation | H1 / Q2-FY21
EARNINGS PRESENTATION | H1 / Q2-FY21
Slide 3: Executive Summary
Executive Summary Overview • Oriental Aromatics Ltd. is one of the largest Indian manufacturers of a variety of Aroma Chemicals, Camphor, Fragrances and Flavours. • The company is one of the privileged few integrated manufacturers of fragrances and flavours as well as aroma chemicals globally. • The
Slide 4: Company Overview
3 Company Overview
Slide 5: Company Overview
Company Overview • The Fragrance and Flavours business of Oriental Aromatics was founded by Mr. Keshavlal Bodani in Fragrances 1955 and has been nurtured and handed down to three generations of the Bodani’s. • In August 2008, Oriental Aromatics’ promoters acquired a controlling stake of 57.66% in th
Slide 6: Value Chain
Value Chain Sources of Raw Raw Materials Products/Blends Applications Materials Aroma Ingredients Incense Sticks Speciality Aroma Chemicals Pine Oil Air Fresheners Terpene based aroma chemicals Pine Tree Others Cosmetics Synthetic Camphor Alpha Pinene Pooja Fragrance and Flavour Products Petroleum B
Slide 7: H1/Q2-FY21 Financial Overview
6 H1/Q2-FY21 Financial Overview
Slide 8: H1 / Q2-FY21 Financial Highlights
H1 / Q2-FY21 Financial Highlights Q2- FY21 Standalone Performance: Q2- FY21 Consolidated Performance: • Revenue from Operations: INR 1,838 Mn • Revenue from Operations: INR 1,838 Mn • EBITDA : INR 491 Mn • EBITDA : INR 490 Mn • EBITDA Margins: 26.71% • EBITDA Margins: 26.66% • Net Profit: INR 332 Mn
Slide 9: Q2-FY21 Operational Highlights
Q2-FY21 Operational Highlights • During the quarter, with gradual lifting of the lockdown, the company witnessed a healthy demand for all the products. • Production volumes on a Y-o-Y basis were better for most of the products. This points to all our manufacturing sites reaching pre Covid production
Slide 10: Q2-FY21 Standalone Income Statement (IND-AS)
Q2-FY21 Standalone Income Statement (IND-AS) Particulars (INR Mn) Q2-FY21 Q2-FY20 Y-O-Y Q1-FY21 Q-O-Q Revenue from Operations 1,838 2,042 (10.0)% 1,133 62.2% Total Expenses 1,347 1,771 (23.9)% 950 41.8% EBITDA 491 271 81.2% 183 168.3% EBITDA Margin (%) 26.71% 13.27% NA 16.15% NA Other Income 3 15 (8
Slide 11: H1-FY21 Standalone Income Statement (IND-AS)
H1-FY21 Standalone Income Statement (IND-AS) Particulars (INR Mn) H1-FY21 H1-FY20 Y-O-Y Revenue from Operations 2,971 4,159 (28.6)% Total Expenses 2,292 3,525 (35.0)% EBITDA 679 634 7.1% EBITDA Margin (%) 22.85% 15.24% 761 Bps Other Income 5 16 (68.8)% Depreciation 92 92 NA Finance Cost 11 67 (83.6)
Slide 12: Q2-FY21 Consolidated Income Statement (IND-AS)
Q2-FY21 Consolidated Income Statement (IND-AS) Particulars (INR Mn) Q2-FY21 Q2-FY20 Y-O-Y Q1-FY21 Q-O-Q Revenue from Operations 1,838 2,042 (10.0)% 1,133 62.2% Total Expenses 1,348 1,767 (23.7)% 949 42.0% EBITDA 490 275 78.2% 184 166.3% EBITDA Margin (%) 26.66% 13.47% NA 16.24% NA Other Income 5 17
Slide 13: H1-FY21 Consolidated Income Statement (IND-AS)
H1-FY21 Consolidated Income Statement (IND-AS) Particulars (INR Mn) H1-FY21 H1-FY20 Y-O-Y Revenue from Operations 2,971 4,163 (28.6)% Total Expenses 2,293 3,531 (35.1)% EBITDA 678 632 7.3% EBITDA Margin (%) 22.82% 15.18% 764 Bps Other Income 5 18 (72.2)% Depreciation 92 92 NA Finance Cost 10 67 (85.
Slide 14: Historical Financial Overview
13 Historical Financial Overview
Slide 15: Historical Standalone Income Statement (IND-AS)
Historical Standalone Income Statement (IND-AS) Income Statement (Mn) FY18 FY19 FY20 H1-FY21 Total Operational Income 5,057 7,526 7,594 2,971 Total Expenses 4,398 6,372 6,319 2,292 EBITDA 659 1,154 1,275 679 EBITDA Margin (%) 13.03% 15.33% 16.79% 22.85% Other Income 41 13 70 5 Depreciation 148 177 1
Slide 16: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Liabilities (INR Mn) FY19 FY20 H1-FY21 Assets (INR Mn) FY19 FY20 H1-FY21 Shareholders Fund Assets Share Capital 168 168 168 Non-Current Assets Other Equity 3,752 4,470 4,898 Property, Plant and Equipment 1,941 1,814 1,755 Intangible Asset 58 24 7 Non-Current Liabi
Slide 17: Historical Consolidated Income Statement (IND-AS)
Historical Consolidated Income Statement (IND-AS) Income Statement (Mn) FY18 FY19 FY20 H1-FY21 Total Operational Income 5,060 7,547 7,599 2,971 Total Expenses 4,413 6,397 6,335 2,293 EBITDA 647 1,150 1,264 678 EBITDA Margin (%) 12.79% 15.24% 16.63% 22.82% Other Income 4 13 74 5 Depreciation 148 178
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Liabilities (INR Mn) FY19 FY20 H1-FY21 Assets (INR Mn) FY19 FY20 H1-FY21 Shareholders Fund Assets Share Capital 168 168 168 Non-Current Assets Other Equity 3,751 4,473 4,901 Property, Plant and Equipment 1,941 1,815 1,755 Goodwill on Amalgamation 450 450 450 Cap
Slide 19: Financial Performance (Consolidated)
Financial Performance (Consolidated) Revenue from Operations (INR Mn) EBITDA (INR Mn) EBITDA MARGIN (%) PAT (INR Mn) PAT MARGIN (%) 16.63% 11.34% 15.20% 18.00% 16.00% 7,599 7,547 12.41% 12.79% 1,264 14.00% 862 7.57% 1,147 12.00% 6.10% 10.00% 4.94% 5,060 4,577 571 8.00% 647 6.00% 568 4.00% 279 250 2.
Slide 20: Capital Market Information
Capital Market Information 150% 100% 50% 0% -50% Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Sensex OAL Price Data (30th September, 2020) INR Shareholding Pattern as on 30th September, 2020 Face Value 5.0 CMP 351.0 52 Week H/L (INR) 424.4/117.05 Public 25.60%
Slide 21: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Oriental Aromatics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any s
Slide 22: Slide 22